Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

v3.23.1
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
 [1]
Dec. 31, 2020
Profit or loss [abstract]      
Revenues $ 54,335 $ 34,053 $ 15,890
Cost of revenues 43,044 25,458 7,081
Gross profit before fair value adjustments 11,291 8,595 8,809
Fair value adjustments:      
Unrealized change in fair value of biological assets (315) 6,308 11,781
Realized fair value adjustments on inventory sold in the year (1,814) (8,570) (10,122)
Total fair value adjustments (2,129) (2,262) 1,659
Gross profit after fair value adjustments 9,162 6,333 10,468
General and administrative expenses 21,460 17,221 11,549
Selling and marketing expenses 11,473 6,725 3,782
Restructuring expenses 4,383 0 0
Share-based compensation 2,637 5,422 3,382
Total operating expenses 39,953 29,368 18,713
Profit (loss) from operating activities (30,791) (23,035) (8,245)
Finance income 6,703 23,544 277
Finance expenses (1,972) (673) (20,504)
Finance income (expense), net 4,731 22,871 (20,227)
Loss before income taxes (26,060) (164) (28,472)
Income tax expense (benefit) (1,138) 500 262
Net loss from continuing operations (24,922) (664) (28,734)
Net loss from discontinued operations, net of tax (166,379) (17,854) 0
Net loss (191,301) (18,518) (28,734)
Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:      
Remeasurement gain (loss) on defined benefit plans 59 21 (30)
Exchange differences on translation to presentation currency (1,238) 858 1,144
Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods (1,179) 879 1,114
Other comprehensive income that will be reclassified to profit or loss in subsequent periods:      
Adjustments arising from translating financial statements of foreign operation (246) 530 (124)
Total other comprehensive income (loss) (1,425) 1,409 990
Total comprehensive loss (192,726) (17,109) (27,744)
Net loss attributable to:      
Equity holders of the Company (188,890) (17,763) (28,698)
Non-controlling interests (2,411) (755) (36)
Net Loss (191,301) (18,518) (28,734)
Total comprehensive income (loss) attributable to:      
Equity holders of the Company (190,162) (16,357) (27,808)
Non-controlling interests (2,564) (752) 64
Total comprehensive loss $ (192,726) $ (17,109) $ (27,744)
Earnings (loss) per share attributable to equity holders of the Company from continuing operations:      
Basic earnings (loss) per share (in CAD) $ (3.13) $ 0.02 $ (1.9)
Diluted loss per share (in CAD) (3.81) (3.62) (1.9)
Basic loss per share (in CAD) (23.17) (3.08) 0
Diluted loss per share (in CAD) (23.17) (3.08) 0
Basic earnings (loss) per share (in CAD) (26.3) (3.06) (1.9)
Diluted loss per share (in CAD) $ (26.98) $ (6.7) $ (1.9)
[1] Reclassified in respect of discontinued operations - see Note 24.